Healthcare Headlines
FT.com - Health
FT.com - Health
  • Billionaire Merckle commits suicide
    Adolf Merckle, one of Germany's wealthiest men, committed suicide after weeks of talks with creditors designed to save his businesses from being consumed by disastrous investments and the global financial crisis

  • Taking BTG along an innovative route
    The biotech company is repositioning following the merger with Protherics. But of more interest than the enlarged company's size is the transformation that BTG is undergoing as it attempts to capture a larger share of the value of its drugs – by marketing its own products

  • Safe becomes sexy when risk is a dirty word
    As investors seek safer havens, the focus of European equity analysts is likely to remain on the traditionally defensive sectors of pharmaceuticals and telecommunications

  • Daiichi to book $3.9bn loss on Ranbaxy
    Daiichi Sankyo said its full-year profits will be lower than initially expected due to a Y360bn loss arising from its acquisition of the Indian generic drugmaker

  • Medical aid trickles through border
    Medical aid trickled into Gaza yesterday through the Rafah crossing on the border with Egypt, while Palestinian ambulances brought out the injured who could not be...

  • Daiichi Sankyo needs miracle cure for Indian poison
    The stoicism of Daiichi Sankyo's board is remarkable. A deal it struck to buy India's Ranbaxy Laboratories in June - in retrospect at the top of the market - has...

  • Taking BTG along an innovative route
    When BTG merged with Protherics just over a month ago, Britain's biggest biotechnology group was born. The merger, announced in August and completed in early December,...

  • Ark lifted by Cerepro European trial approval
    Ark Therapeutics received a fillip after Cerepro, the company's lead brain cancer drug, was accepted for submission to European drug regulators. The news means that...

  • Pharma buying spree could swallow biotechs
    Some of the world's biggest pharmaceuticals companies are likely to embark on a buying spree as patent expiries combine with a greater willingness from biotechs to sell out

  • New year's resolutions
    The new year brings attempts to stop smoking and lose weight, but should cash-strapped consumers save their pennies as recession bites?


Robyne Wilkerson
Our other Physiatry Related Sites by PM&R Resources R. Wilkerson